An observational study in Autoimmune Diseases and Menopause, sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. Not yet recruiting at 1 site in Italy. Open to female participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-25.
Sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia · Observational
The goal of this observational study is to investigate the prevalence of autoimmune or immune-mediated conditions in women during the menopausal transition (aged 40-60 years). The main questions it aims to answer are:
Participants will complete evaluations, provide samples for clinical, immunological, and biochemical markers, and undergo assessments to analyze symptom burden and psychosocial determinants during the menopausal transition.
802 studies on the registry are indexed under Autoimmune Diseases; 271 are open to participants now.
This study's planned enrollment of 300 is close to the median of 300 across 229 observational studies indexed under Autoimmune Diseases.
Browse Autoimmune Diseases studies →Fondazione IRCCS Policlinico San Matteo di Pavia is the lead sponsor of 257 studies on the registry; 114 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women referred to the menopause clinic for the management of climacteric symptoms, perimenopausal menstrual irregularities, and/or the prevention of menopause-associated conditions, alongside women referred to an internal medicine outpatient clinic dedicated to the diagnosis and treatment of immune-mediated gastrointestinal diseases
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prevalence of autoimmune or immune-mediated conditions during the menopausal transition
Time frame: At the baseline visit (cross-sectional assessment)
Start is estimated for Sep 2026; primary completion for Sep 2028, 24 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondazione IRCCS Policlinico San Matteo di Pavia →